NCT05819892 2026-03-11
Phase I Trial Testing the Safety and Tolerability of Chemoradiation Followed by Chemotherapy + Dostarlimab for Stage IIIC, Node Positive, Endometrial Cancer
M.D. Anderson Cancer Center
Phase 1 Recruiting
Clinical Trials
9 trialsNCT05857631 2025-04-15
PARCERII
Tata Memorial Centre
Phase NA Recruiting
NCT05255653 2024-11-29
RAINBO
Leiden University Medical Center
Phase 2/3 Recruiting
NCT00411138 2023-10-11
PORTEC-3
Leiden University Medical Center
Phase 3 Unknown
NCT05489848 2022-08-05
Chemotherapy vs Chemoradiotherapy for Post-operative Endometrial Cancer Patients With P53-mutation
Fudan University
Phase 2/3 Not yet recruiting
NCT01461746 2017-05-31
Efficacy Study of Chemotherapy Followed by Radiation Therapy to Treat Endometrial Cancer
Asan Medical Center
Phase 2 Unknown
NCT01461759 2017-05-31
Efficacy Study of Chemotherapy to Treat Advanced or Recurrent Endometrial Cancer
Asan Medical Center
Phase 2 Unknown
NCT00448643 2016-12-15
Whole-Abdominal Radiation Therapy and Cisplatin in Treating Patients With Stage III or Stage IV Endometrial Cancer That Has Been Removed by Surgery
University of Miami
Phase 1 Completed
NCT00388154 2014-11-13
Gemcitabine and Cisplatin for Advanced or Recurrent Endometrial Cancer
M.D. Anderson Cancer Center
Phase 2 Completed